Literature DB >> 13118170

The requirement for a hydrazine-sensitive serum factor and heat-labile serum factors in the inactivation of human C'3 by zymosan.

L PILLEMER, I H LEPOW, L BLUM.   

Abstract

Entities:  

Keywords:  COMPLEMENT; YEASTS

Mesh:

Substances:

Year:  1953        PMID: 13118170

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  10 in total

1.  [Methodological and clinical studies on the properdin system. III. Studies on the behavior of 4 complement components after major gynecological operations].

Authors:  G SCHUMACHER; H D SCHLUMBERGER
Journal:  Arch Gynakol       Date:  1961

Review 2.  The internal thioester and the covalent binding properties of the complement proteins C3 and C4.

Authors:  S K Law; A W Dodds
Journal:  Protein Sci       Date:  1997-02       Impact factor: 6.725

Review 3.  Activation of the complement system.

Authors:  W Vogt
Journal:  Agents Actions       Date:  1983-08

4.  Anticomplementary activity of Fusobacterium polymorphum in normal and C4-deficient sources of guinea pig complement.

Authors:  C E Hawley; W A Falkler
Journal:  Infect Immun       Date:  1977-10       Impact factor: 3.441

Review 5.  Properdin: approaching four decades of research.

Authors:  K K Maves; J M Weiler
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

6.  Opsonic requirements for phagocytosis of Legionella micdadei by polymorphonuclear leukocytes.

Authors:  D O Steffensen; D L Weinbaum; J N Dowling
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

7.  Nonspecific complement activation by streptococcal structures. II. Properdin-independent initiation of the alternate pathway.

Authors:  J W Tauber; M J Polley; J B Zabriskie
Journal:  J Exp Med       Date:  1976-06-01       Impact factor: 14.307

8.  Inactivation of endotoxin by a humoral component. II. Interaction of endotoxin with serum and plasma.

Authors:  R C SKARNES; F S ROSEN; M J SHEAR; M LANDY
Journal:  J Exp Med       Date:  1958-11-01       Impact factor: 14.307

9.  The properdin system and immunity. III. The zymosan assay of properdin.

Authors:  L PILLEMER; L BLUM; I H LEPOW; L WURZ; E W TODD
Journal:  J Exp Med       Date:  1956-01-01       Impact factor: 14.307

10.  Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase.

Authors:  D T Fearon; K F Austen
Journal:  J Exp Med       Date:  1975-10-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.